Provided by Tiger Trade Technology Pte. Ltd.

DIAGENS-B

430.200
+2.0000.47%
Volume:54.25K
Turnover:23.61M
Market Cap:38.24B
PE:-512.74
High:450.800
Open:410.000
Low:410.000
Close:428.200
52wk High:765.500
52wk Low:178.000
Shares:88.88M
HK Float Shares:88.88M
Volume Ratio:0.36
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.839
ROE:-39.50%
ROA:-23.53%
PB:42.19
PE(LYR):-512.74
PS:178.36

Loading ...

港股动态 | DIAGENS-B飙升逾10% 模型业务收入激增带动业绩领跑行业

Stock News
·
Yesterday

How to Pick AI Stocks in Hong Kong? DIAGENS-B (02526): A Rare Vertical AI Play with High Growth and Strong Moat

Stock News
·
Sep 05

DIAGENS-B Joins Southbound Trading, Opening Direct Access for Mainland Investors

Stock News
·
Sep 04

DIAGENS-B and Hong Kong Polytechnic University Join Forces to Advance Medical AI With New Joint Lab

Stock News
·
Sep 04

Quarterly Index Review Approaching: How Passive Capital and Mainland Connect Opportunities Are Shaping Hong Kong Market Dynamics

Stock News
·
Sep 04

HK Stocks in Focus: DIAGENS-B (02526.HK) Jumps Over 9% as Hang Seng Composite Index Inclusion Takes Effect September 7

Stock News
·
Sep 02

医疗AI龙头午盘飙升逾9%,券商首予买入评级看好三年十倍增长

Deep News
·
Aug 28

HK Stocks in Focus: DIAGENS-B Surges Nearly 9% in Morning Trade Following Inclusion in 23 Hang Seng Indexes

Stock News
·
Aug 28

Hong Kong Stocks Close: Hang Seng Falls 1.89% as Optical Communication Stocks Plunge, Alibaba Drops 8% on $10.2B AI-Focused Share Placement

Stock News
·
Aug 24

DIAGENS-B Surges Over 29% to Record High on Dual Index Inclusion

Deep News
·
Aug 24

Diagens-B Set to Join Multiple Hang Seng Index Constituent Lists

Stock News
·
Aug 24

Hangzhou Diagens Joins Hang Seng Composite Index Constituents from Sept. 7, 2026

Reuters
·
Aug 24

Dual Index Inclusion: DIAGENS-B (02526) Added to Both Hang Seng Composite and Hang Seng Biotechnology Indices, Unlocking Significant Valuation Upside

Stock News
·
Aug 22

AI-Driven Cancer Vaccine Success Propels DIAGENS-B to Record High, Index Inclusion on the Horizon

Deep News
·
Aug 21

Hong Kong Stocks Close Higher: Vaccine Sector Surges on Historic mRNA Cancer Trial Breakthrough, Gold Miners Rally Again

Stock News
·
Aug 20

Diagens-B Surges Over 21% in Morning Trade as Model Service Revenue Soars 101.1% in First Half

Deep News
·
Aug 20

Diagens Tech (02526.hk): Model‑as‑a‑Service Revenue Surges 101.1% Year‑Over‑Year; Commercial Rollout of Its Medical Imaging AI Platform Gathers Momentum

THOMSON REUTERS
·
Aug 11

From Functional to Commercial: DIAGENS-B (02526) Interim Results Signal a Platform Value Reassessment for Medical AI

Stock News
·
Aug 10

Diagens Biotechnology's H1 Loss Widens

MT Newswires Live
·
Aug 07

Diagens Reports 1H26 Revenue Up 21% to RMB108.69 Million; Model Services Double, Net Loss Expands on Higher R&D Spend

Bulletin Express
·
Aug 07